ATE387507T1 - Screeningverfahren für die oligonukleotidtransfektion - Google Patents
Screeningverfahren für die oligonukleotidtransfektionInfo
- Publication number
- ATE387507T1 ATE387507T1 AT01992188T AT01992188T ATE387507T1 AT E387507 T1 ATE387507 T1 AT E387507T1 AT 01992188 T AT01992188 T AT 01992188T AT 01992188 T AT01992188 T AT 01992188T AT E387507 T1 ATE387507 T1 AT E387507T1
- Authority
- AT
- Austria
- Prior art keywords
- peptoids
- screening method
- oligonucleotide transfection
- transfection
- screening
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0491—Sugars, nucleosides, nucleotides, oligonucleotides, nucleic acids, e.g. DNA, RNA, nucleic acid aptamers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/88—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation using microencapsulation, e.g. using amphiphile liposome vesicle
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/582—Recycling of unreacted starting or intermediate materials
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Optics & Photonics (AREA)
- Gastroenterology & Hepatology (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US25797500P | 2000-12-23 | 2000-12-23 | |
US32918501P | 2001-10-11 | 2001-10-11 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE387507T1 true ATE387507T1 (de) | 2008-03-15 |
Family
ID=26946324
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT01992188T ATE387507T1 (de) | 2000-12-23 | 2001-12-18 | Screeningverfahren für die oligonukleotidtransfektion |
Country Status (9)
Country | Link |
---|---|
US (1) | US7422861B2 (de) |
EP (1) | EP1404867B1 (de) |
JP (2) | JP2005502309A (de) |
AT (1) | ATE387507T1 (de) |
CA (1) | CA2431219C (de) |
DE (1) | DE60133049T2 (de) |
ES (1) | ES2300379T3 (de) |
PT (1) | PT1404867E (de) |
WO (1) | WO2002052046A2 (de) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6783929B1 (en) * | 1999-11-02 | 2004-08-31 | Chiron Corporation | Biological sample component purification and differential display |
US7026166B2 (en) * | 2002-01-22 | 2006-04-11 | Chiron Corporation | Fluorogenic dyes |
US7704756B2 (en) * | 2003-01-21 | 2010-04-27 | Novartis Vaccines And Diagnostics, Inc. | Fluorogenic dyes |
AU2004305111B2 (en) * | 2003-12-19 | 2011-04-28 | Novartis Vaccines And Diagnostics, Inc. | Cell transfecting formulations of small interfering RNA, related compositions and methods of making and use |
EP1931695B1 (de) | 2005-09-09 | 2013-04-10 | Novartis AG | Prionspezifische Peptoidreagentien |
WO2010017412A1 (en) | 2008-08-06 | 2010-02-11 | The Regents Of The University Of California | Novel biomimetic peptoid polymers |
US10001478B2 (en) | 2013-08-21 | 2018-06-19 | Mycartis Nv | Heterogenous surface functionalization |
WO2017066454A2 (en) | 2015-10-14 | 2017-04-20 | X-Therma, Inc. | Compositions and methods for reducing ice crystal formation |
NL2029057B1 (en) * | 2021-08-06 | 2023-02-21 | Nutcracker Therapeutics Inc | Compositions comprising hydroxyethyl-capped cationic peptoids |
AU2022323376A1 (en) * | 2021-08-06 | 2024-02-22 | Nutcracker Therapeutics, Inc. | Compositions comprising hydroxyethyl-capped cationic peptoids |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IE66205B1 (en) | 1990-06-14 | 1995-12-13 | Paul A Bartlett | Polypeptide analogs |
US5650489A (en) | 1990-07-02 | 1997-07-22 | The Arizona Board Of Regents | Random bio-oligomer library, a method of synthesis thereof, and a method of use thereof |
US5264419A (en) | 1990-08-31 | 1993-11-23 | Warner-Lambert Company | N-substituted cycloalkyl and polycycloalkyl α-substituted TRP derivatives |
AU4779493A (en) * | 1992-07-21 | 1994-02-14 | Bunsen Rush Laboratories Inc. | Oligomer library formats and methods relating thereto |
AU679945B2 (en) | 1992-09-24 | 1997-07-17 | Chiron Corporation | Synthesis of N-substituted oligomers |
US5877278A (en) | 1992-09-24 | 1999-03-02 | Chiron Corporation | Synthesis of N-substituted oligomers |
EP0675873A4 (de) | 1992-12-11 | 2000-03-29 | Chiron Corp | Herstellung von kodierten polymeren |
IL106106A0 (en) | 1993-06-22 | 1993-10-20 | Interpharm Lab Ltd | Library of polymeric molecules and its preparation |
GB2295152A (en) | 1994-11-18 | 1996-05-22 | Pfizer Ltd | Preparation of a library of compounds by solid-phase synthesis |
US5481020A (en) | 1994-12-30 | 1996-01-02 | Chiron Corporation | Opiate receptor ligands |
US5958792A (en) | 1995-06-07 | 1999-09-28 | Chiron Corporation | Combinatorial libraries of substrate-bound cyclic organic compounds |
US5935936A (en) * | 1996-06-03 | 1999-08-10 | Genzyme Corporation | Compositions comprising cationic amphiphiles and co-lipids for intracellular delivery of therapeutic molecules |
ATE252914T1 (de) | 1996-08-13 | 2003-11-15 | Chiron Corp | Zusammensetzungen zur polynukleotidabgabe |
EP1007966A4 (de) | 1996-08-21 | 2001-10-17 | Smithkline Beecham Corp | Schnellverfahren zum gruppieren und synthesieren von wulstbasierenden kombinatorischen bibliotheken |
WO1998010857A1 (en) | 1996-09-12 | 1998-03-19 | Chiron Corporation | Actuation means for use in solid phase chemical synthesis involving arrays of modular reaction vessels |
EP0934113B1 (de) | 1996-10-22 | 2002-04-03 | Chiron Corporation | Umkehrfiltrationsvorrichtung sowie anwendungsverfahren |
US6153596A (en) * | 1996-12-18 | 2000-11-28 | Emory University | Polycationic oligomers |
EP0979236B1 (de) | 1997-04-28 | 2009-07-29 | Novartis Vaccines and Diagnostics, Inc. | Vorrichtung zur herstellung von oligomeren, insbesondere peptoiden, mit rückführung der reagenzien |
US6197332B1 (en) * | 1997-08-13 | 2001-03-06 | Chiron Corporation | Lipid-conjugated polyamide compounds and related compositions and methods thereof |
EP1075455A2 (de) | 1998-05-08 | 2001-02-14 | Chiron Corporation | Methode und gerät zu nonsynthetischer deconvolution |
EP1144609B1 (de) | 1999-08-27 | 2008-03-05 | Novartis Vaccines and Diagnostics, Inc. | Chimerische antisense-oligonukleotide und zelltransfektions-zusammensetzungen davon |
-
2001
- 2001-12-18 CA CA2431219A patent/CA2431219C/en not_active Expired - Fee Related
- 2001-12-18 EP EP01992188A patent/EP1404867B1/de not_active Expired - Lifetime
- 2001-12-18 AT AT01992188T patent/ATE387507T1/de active
- 2001-12-18 PT PT01992188T patent/PT1404867E/pt unknown
- 2001-12-18 DE DE60133049T patent/DE60133049T2/de not_active Expired - Lifetime
- 2001-12-18 ES ES01992188T patent/ES2300379T3/es not_active Expired - Lifetime
- 2001-12-18 WO PCT/US2001/049175 patent/WO2002052046A2/en active IP Right Grant
- 2001-12-18 US US10/025,423 patent/US7422861B2/en not_active Expired - Fee Related
- 2001-12-18 JP JP2002553525A patent/JP2005502309A/ja active Pending
-
2007
- 2007-09-28 JP JP2007256754A patent/JP4611357B2/ja not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US7422861B2 (en) | 2008-09-09 |
DE60133049T2 (de) | 2009-02-19 |
JP2005502309A (ja) | 2005-01-27 |
JP2008086318A (ja) | 2008-04-17 |
ES2300379T3 (es) | 2008-06-16 |
DE60133049D1 (de) | 2008-04-10 |
CA2431219C (en) | 2012-02-07 |
PT1404867E (pt) | 2008-06-05 |
EP1404867A2 (de) | 2004-04-07 |
WO2002052046A3 (en) | 2004-02-12 |
EP1404867B1 (de) | 2008-02-27 |
JP4611357B2 (ja) | 2011-01-12 |
CA2431219A1 (en) | 2002-07-04 |
WO2002052046A2 (en) | 2002-07-04 |
US20020151062A1 (en) | 2002-10-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE387507T1 (de) | Screeningverfahren für die oligonukleotidtransfektion | |
EP1590476A4 (de) | Proteinfragment komplementationstests zum screening mit hohem durchsatz und hohem gehalt | |
DK1143006T3 (da) | Vektorer/DNA-sekvenser fra humane kombinatoriske antistofbiblioteker | |
ATE516497T1 (de) | Screening für funktionshomologien | |
Ezer et al. | Homotypic clusters of transcription factor binding sites: A model system for understanding the physical mechanics of gene expression | |
DE69824586D1 (de) | Probenträger hoher dichte für die analyse biologischer proben | |
ATE408455T1 (de) | Arrayplatten und verfahren zur herstellung von arrayplatten | |
CY1108634T1 (el) | Μεθοδος και συσκευη για την προετοιμασια δειγματων ιστου για παραλληλη αναλυση | |
DE60136324D1 (de) | Vorrichtung zum auswerten biologischer informationen | |
WO2002010750A3 (en) | Biosensors, reagents and diagnostic applications of directed evolution | |
GB2308692B (en) | A forecasting control system and method | |
DE50111819D1 (de) | Verwendung einer mikrobiologischen kultur für die einleitung von mikrobiologischen abläufen in der aquaristik | |
IS7611A (is) | Örfylki og aðferð til þess að framkvæma blöndunarhvörf fyrir fjölda sýna á einu örfylki | |
ATE409236T1 (de) | Derivatisierte nukleinsäuren und deren verwendung | |
NZ597400A (en) | Methods and Materials Using Signaling Probes | |
FR2781770B1 (fr) | Echantillon de produit fluide | |
DE602005023710D1 (de) | Dna-array zur analyse der dna-methylierung, konstruktionsverfahren dafür sowie verfahren zur analyse der dna-methylierung | |
ATE525128T1 (de) | Selektive methanizierung von kohlenmonoxide in einem wasserstoffreichen brennstoff | |
WO2002004597A3 (en) | Method and apparatus for synthesis of arrays of dna probes | |
ATE377753T1 (de) | Nachweis von dna-bindungsproteinen | |
WO2003089901A3 (en) | Methods for preparing libraries of unique tags and related screening methods | |
NO994873D0 (no) | Metode for syntese og analyse av kombinatoriske kjemibiblioteker | |
DE60331686D1 (de) | Mikroarray-vorrichtungen mit steuerbarem reaktionsvolumen | |
DE60141221D1 (de) | Verfahren zur genexpressionsanalyse | |
AU2019274469A1 (en) | Single cell mapping and transcriptome analysis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1404867 Country of ref document: EP |